Imerys provides update on the ongoing US talc-related litigation

On November 5, 2024, the U.S. Bankruptcy Court overseeing the Chapter 11 cases of Imerys’ North American talc subsidiaries (the “NA Talc Entities”) has approved the Disclosure Statement of the revised Plan of Reorganization and authorized its submission to the vote of relevant creditors and claimants. 

The result of this vote is expected in the coming months and, if positive, it should enable the NA Talc Entities to move closer to a final resolution of their Chapter 11. 

The provision currently recognized in Imerys financial statements is considered as appropriate to cover the expected financial impact of the Plan of Reorganization and the resolution of Group’s historic liabilities relating to the North American talc operations.

Imerys is the world’s leading supplier of mineral-based specialty solutions for the industry with €3.8 billion in revenue and 13,700 employees in 54 countries in 2023. The Group offers high value-added and functional solutions to a wide range of industries and fast-growing markets such as solutions for the energy transition and sustainable construction, as well as natural solutions for consumer goods. Imerys draws on its understanding of applications, technological knowledge, and expertise in material science to deliver solutions which contribute essential properties to customers’ products and their performance. As part of its commitment to responsible development, Imerys promotes environmentally friendly products and processes in addition to supporting its customers in their decarbonization efforts. 

Imerys is listed on Euronext Paris (France) with the ticker symbol NK.PA. 

More comprehensive information about Imerys may be obtained from its website (www.imerys.com) in the Regulated Information section, particularly in its Registration Document filed with the French financial markets authority (Autorité des marchés financiers, AMF) on March 26, 2024 under number D.24-0183 (also available from the AMF website, www.amf-france.org). Imerys draws investors’ attention to chapter 2 “Risk Factors and Internal Control” of its Registration Document.

Analyst/Investor Relations: 

Cyrille Arhanchiague : +33 (0)6 07 16 67 26 

finance@imerys.com 

Press contacts: 

Claire Garnier : +33 (0)1 49 55 64 27 

Mathieu Gratiot : +33 (0)7 87 53 46 60 

Hugues Schmitt (Primatice) : +33 (0)6 71 99 74 58